A Clinical Study to Explore the Safety and Efficacy of CT0991 in Relapsed/ Refractory Acute Myeloid Leukemia

Status:
NOT_YET_RECRUITING

Trial end date:
2027-05-30

Target enrollment:

Participant gender:

A Clinical Study to Investigate the Safety and Efficacy of CT0991 in Patients with Relapsed/Refractory Acute Myeloid Leukemia.

PHASE1

MEI HENG